Stem Cells May Improve Dialysis Access for Kidney Disease Patients

Published on Mayo Clinic News Network

Mayo Clinic researchers report that fat-derived mesenchymal stem cells can help prevent vein narrowing in dialysis access for end-stage kidney disease. In a Phase 1 trial, patients who received stem cells with their arteriovenous fistula surgery showed faster healing and greater durability. The study also identified genetic biomarkers that may predict which patients benefit most, opening the way to personalized therapies.

👉 Read the full article: Stem cells may offer new hope for end-stage kidney disease treatment

Disclaimer

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link. SSCTR does not provide medical advice, and the views expressed are for educational purposes only.